trending Market Intelligence /marketintelligence/en/news-insights/trending/CsfsllQnD6XtaUKhFenbCw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Oxford Immunotec starts offering for ordinary shares

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

Oxford Immunotec starts offering for ordinary shares

Oxford Immunotec Global PLC will sell 2.5 million ordinary shares in an underwritten public offering.

The company has granted the underwriter an option to buy up to 375,000 additional shares.

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

BTIG LLC is acting as sole underwriter for the offering.